首页
期刊导航
期刊检索
论文检索
新闻中心
期刊
期刊
论文
首页
>
《癌症生物学与医学:英文版》
>
2018年2期
>
Primary resistance to crizotinib treatment in a non-small cell lung cancer patient with an EML4-ALK rearrangement:a case report
Primary resistance to crizotinib treatment in a non-small cell lung cancer patient with an EML4-ALK rearrangement:a case report
打印
分享
在线阅读
下载PDF
导出详情
摘要
未填写
DOI
ldeqezxnd3/1839441
作者
Ling Zhang;Yunxia Li;Shaohong Zhang;Chen Gao;Keke Nie;Youxin Ji
机构地区
不详
出处
《癌症生物学与医学:英文版》
2018年2期
关键词
癌症病人
房间
案例
治疗
肺
等位基因
分类
[医药卫生][肿瘤]
出版日期
2018年02月12日(中国期刊网平台首次上网日期,不代表论文的发表时间)
相关文献
1
Peng Wang;Pei Xiao;Yingnan Ye;Pengpeng Liu;Lei Han;Li Dong;Chunhua She;Jinpu Yu.
Rapid response of brain metastasis to crizotinib in a patient with KLC1-ALK fusion and MET gene amplification positive non-small cell lung cancer:a case report
.肿瘤,2017-02.
2
Zhao Zhi-Mei,Wang Song-Ping,Sun Lei,Ji You-Xin.
Crizotinib plus erlotinib overcomes osimertinib resistance in a seriously-ill non-small cell lung cancer patient with acquired MET amplification
.医药卫生,2021-03.
3
Siyuan Ren,Mengyao Ma,Chuan He,Yuhui Deng,Xiaoyun Chen,Yonglin Liu,Yangyang Jin,Yansong Liu,Lei Cai,Lin He.
Placebo effect in the treatment of non-small cell lung cancer: a meta-analysis
.医药卫生,2022-12.
4
Arpita Desai;Smitha P.Menon;Grace K.Dy.
Alterations in genes other than EGFR/ALK/ROS1 in non-small cell lung cancer:trials and treatment options
.肿瘤,2016-01.
5
Zhou Fei,Zhou Cai-Cun.
Immunotherapy in non-small cell lung cancer: advancements and challenges
.医药卫生,2021-05.
6
Li Chu-Ling,Song Yong.
Combination strategies of immunotherapy in non-small cell lung cancer: facts and challenges
.医药卫生,2021-09.
7
Yu-Sook Jeong;Hye-Suk Han;Sung-Nam Lim;Mi-Jin Kim;Joung-Ho Han;Min-Ho Kang;Dong-Hee Ryu;Ok-Jun Lee;Ki-Hyeong Lee;Seung-Taik Kim.
Gallbladder Metastasis of Non-small Cell Lung Cancer Presenting as Acute Cholecystitis
.肿瘤,2012-03.
8
单根法;钟竑;张辅贤;李国庆;隆桂麟;顾鹤定;戚晓敏.
Expression and Prognostic Significance of Multidrug Resistance Associated Protein (MRP) Gene in Non-small Cell Lung Cancer by in Site Hybridization
.肿瘤,2000-03.
9
.
FDA expands approval of Imfinzi to reduce the risk of non-small cell lung cancer progressing
.药学,2018-02.
10
徐光川;戎铁华;林鹏.
ADJUVANT CHEMOTHERAPY FOLLOWING RADICAL SURGERYFOR NON-SMALL CELL LUNG CANCER:A RANDOMIZED STUDY
.肿瘤,1999-01.
来源期刊
癌症生物学与医学:英文版
2018年2期
相关推荐
EXPRESSION OF PHOSPHO-b-CATENIN AND ITS SIGNIFICANCE IN NON-SMALL CELL LUNG CANCER
Brain metastasis in non-small cell lung cancer (NSCLC) patients with uncommon EGFR mutations: a report of seven cases and literature review
Treating non-small cell lung cancer by targeting the PI3K signaling pathway
Radiolabeled cetuximab plus whole-brain irradiation (WBI) for the treatment of brain metastases from non-small cell lung cancer (NSCLC)
Primary Signet Ring Cell Carcinoma of Lung: Report of One Case
同分类资源
更多
[肿瘤]
Different Outcome of Myeloid Sarcoma with Spinal Cord Compression Preceding Acute Myeloid Leukemia: Report of Two Cases and Review of Literatures
[肿瘤]
老年肱骨近端骨折患者的锁定加压钢板内固定与人工肱骨头置换疗效对比分析
[肿瘤]
胶质瘤手术及辅助技术的进展
[肿瘤]
IMMUNOCHEMICAL IDENTIFICATION AND LOCALIZATION OF CYTOCHROME P-450HSjISOZYME, AN ENZYME RELATED TO NITROSAMINE METABOLISM, IN HUMAN GASTRIC MUCOSA AND GASTRIC CARCINOMA
[肿瘤]
专家异地会诊
相关关键词
癌症病人
房间
案例
治疗
肺
等位基因
返回顶部